COPI vesicle formation and N-myristoylation are targetable vulnerabilities of senescent cells
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Drugs that selectively kill senescent cells (senolytics) improve the outcomes of cancer, fibrosis and age-related diseases. Despite their potential, our knowledge of the molecular pathways that affect the survival of senescent cells is limited. To discover senolytic targets, we performed RNAi screens and identified coatomer complex I (COPI) vesicle formation as a liability of senescent cells. Genetic or pharmacological inhibition of COPI results in Golgi dispersal, dysfunctional autophagy, and unfolded protein response-dependent apoptosis of senescent cells, and knockdown of COPI subunits improves the outcomes of cancer and fibrosis in mouse models. Drugs targeting COPI have poor pharmacological properties, but we find that N-myristoyltransferase inhibitors (NMTi) phenocopy COPI inhibition and are potent senolytics. NMTi selectively eliminated senescent cells and improved outcomes in models of cancer and non-alcoholic steatohepatitis. Our results suggest that senescent cells rely on a hyperactive secretory apparatus and that inhibiting trafficking kills senescent cells with the potential to treat various senescence-associated diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225
Self-citationNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Self-citationThe Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584 · cited 1×
“Several senolytics have been identified, including dasatinib and quercetin (referred to as D + Q) 9 , Bcl2 family inhibitors such as ABT-263 and ABT-737 10–12 , a modified FOXO4-p53 interfering peptide 13 , HSP90 inhibitors 14 , cardiac glycosides 15,16 and β-galactosidase-activated nanoparticles…”
BackgroundChemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801
Self-citationSenescence surveillance of pre-malignant hepatocytes limits liver cancer development
Kang, T.-W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D., Hohmeyer, A., Gereke, M., Rudalska, R., Potapova, A., et al. (2011) · Nature · doi:10.1038/nature10599 · Cited by 1,621 · cited 1×
“Next, we employed a model of liver tumour initiation in which senescence is induced in hepatocytes by transposon-mediated transfer of oncogenic NRAS (NRAS G12V ) 55 .”
MethodSelf-citationCellular senescence mediates fibrotic pulmonary disease
Schafer, M. J., White, T. A., Iijima, K., Haak, A. J., Ligresti, G., Atkinson, E. J., Oberg, A. L., Birch, J., Salmonowicz, H., Zhu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms14532 · Cited by 1,613 · cited 5×
“To evaluate their senolytic potential, we tested NMTi in models of cancer, NASH and IPF.”
BackgroundInfluentialSelf-citationJeon, O. H., Kim, C., Laberge, R.-M., Demaria, M., Rathod, S., Vasserot, A. P., Chung, J. W., Kim, D. H., Poon, Y., David, N., et al. (2017) · Nature Medicine · doi:10.1038/nm.4324 · Cited by 1,515 · cited 1×
“The selective killing of p16 INK4a -positive senescent cells (senolysis) in aged normal mice improves healthspan, increases lifespan 4 and also alleviates pathologies such as atherosclerosis 5 , osteo-arthritis 6 and neurodegenerative diseases 7 .”
BackgroundBaar, M. P., Brandt, R. M. C., Putavet, D. A., Klein, J. D. D., Derks, K. W. J., Bourgeois, B. R. M., Stryeck, S., Rijksen, Y., van Willigenburg, H., Feijtel, D. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.031 · Cited by 1,454
From NASH to HCC: current concepts and future challenges
Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0145-7 · Cited by 1,392 · cited 2×
“NASH is associated with chronic inflammation that results in the recruitment and activation of different immune cell populations 59,60 .”
Background
Research works printed but not linked: 39
- Childs, B. G. et al. Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science 354, 472–477 (2016). · DOI · Paper page
- Chen, Q. et al. ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer. Oncotarget 6, 25883–25896 (2015). · DOI · Paper page
- Ellison-Hughes, G. M. First evidence that senolytics are effective at decreasing senescent cells in humans. EBioMedicine 56, 102473 (2020). · DOI · Paper page
- Beck, R., Adolf, F., Weimer, C., Bruegger, B. & Wieland, F. T. ArfGAP1 activity and COPI vesicle biogenesis. Traffic 10, 307–315 (2009). · DOI
- Bethune, J. & Wieland, F. T. Assembly of COPI and COPII vesicular coat proteins on membranes. Annu. Rev. Biophys. 47, 63–83 (2018). · DOI
- Popoff, V. et al. Several ADP-ribosylation factor (Arf) isoforms support COPI vesicle formation. J. Biol. Chem. 286, 35634–35642 (2011). · DOI
- Nebenfuhr, A., Ritzenthaler, C. & Robinson, D. G. Brefeldin A: deciphering an enigmatic inhibitor of secretion. Plant Physiol. 130, 1102–1108 (2002). · DOI · Paper page
- Saenz, J. B. et al. Golgicide A reveals essential roles for GBF1 in Golgi assembly and function. Nat. Chem. Biol. 5, 157–165 (2009). · DOI · Paper page
- Razi, M., Chan, E. Y. & Tooze, S. A. Early endosomes and endosomal coatomer are required for autophagy. J. Cell Biol. 185, 305–321 (2009). · DOI · Paper page
- Hetz, C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat. Rev. Mol. Cell Biol. 13, 89–102 (2012). · DOI · Paper page
- Hollien, J. et al. Regulated Ire1-dependent decay of messenger RNAs in mammalian cells. J. Cell Biol. 186, 323–331 (2009). · DOI · Paper page
- Kitakaze, K. et al. Cell-based HTS identifies a chemical chaperone for preventing ER protein aggregation and proteotoxicity. eLife 8, e43302 (2019). · DOI
- Ito, Y. et al. cis-Golgi proteins accumulate near the ER exit sites and act as the scaffold for Golgi regeneration after brefeldin A treatment in tobacco BY-2 cells. Mol. Biol. Cell 23, 3203–3214 (2012). · DOI
- Krtolica, A., Parrinello, S., Lockett, S., Desprez, P. Y. & Campisi, J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl Acad. Sci. USA 98, 12072–12077 (2001). · DOI · Paper page
- Bauer, J. A. et al. Reversal of cisplatin resistance with a BH3 mimetic, (−)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xL. Mol. Cancer Ther. 4, 1096–1104 (2005). · DOI · Paper page
- Hernandez-Gonzalez, F. et al. Human senescent fibroblasts trigger progressive lung fibrosis in mice. Aging (Albany NY) 15, 6641–6657 (2023). · DOI
- Phillips, L. R., Supko, J. G. & Malspeis, L. Analysis of brefeldin A in plasma by gas chromatography with electron capture detection. Anal. Biochem. 211, 16–22 (1993). · doi:10.1006/abio.1993.1225
- Luo, P. M. & Boyce, M. Directing traffic: regulation of COPI transport by post-translational modifications. Front. Cell Dev. Biol. 7, 190 (2019). · DOI
- Thinon, E. et al. Global profiling of co- and post-translationally N-myristoylated proteomes in human cells. Nat. Commun. 5, 4919 (2014). · DOI · Paper page
- Goya Grocin, A., Serwa, R. A., Morales-Sanfrutos, J., Ritzefeld, M. & Tate, E. W. Whole proteome profiling of N-myristoyltransferase activity and inhibition using sortase A. Mol. Cell Proteom. 18, 115–126 (2019). · DOI
- Kallemeijn, W. W. et al. Validation and invalidation of chemical probes for the human N-myristoyltransferases. Cell Chem. Biol. 26, 892–900 (2019). · DOI
- Timms, R. T. et al. A glycine-specific N-degron pathway mediates the quality control of protein N-myristoylation. Science 365, eaaw4912 (2019). · DOI · Paper page
- Thinon, E., Morales-Sanfrutos, J., Mann, D. J. & Tate, E. W. N-Myristoyltransferase inhibition induces ER-stress, cell cycle arrest, and apoptosis in cancer cells. ACS Chem. Biol. 11, 2165–2176 (2016). · DOI
- Burnaevskiy, N. et al. Proteolytic elimination of N-myristoyl modifications by the Shigella virulence factor IpaJ. Nature 496, 106–109 (2013). · DOI · Paper page
- Burnaevskiy, N., Peng, T., Reddick, L. E., Hang, H. C. & Alto, N. M. Myristoylome profiling reveals a concerted mechanism of ARF GTPase deacylation by the bacterial protease IpaJ. Mol. Cell 58, 110–122 (2015). · DOI
- Kallemeijn, W. W. et al. Proteome-wide analysis of protein lipidation using chemical probes: in-gel fluorescence visualization, identification and quantification of N-myristoylation, N- and S-acylation, O-cholesterylation, S-farnesylation and S-geranylgeranylation. Nat. Protoc. 16, 5083–5122 (2021). · DOI
- Beauchamp, E. et al. Targeting N-myristoylation for therapy of B-cell lymphomas. Nat. Commun. 11, 5348 (2020). · DOI
- Sangha, R. et al. Novel, first-in-human, oral PCLX-001 treatment in a patient with relapsed diffuse large B-cell lymphoma. Curr. Oncol. 29, 1939–1946 (2022). · doi:10.3390/curroncol29030158
- Andoniadou, C. L. et al. Sox2+ stem/progenitor cells in the adult mouse pituitary support organ homeostasis and have tumor-inducing potential. Cell Stem Cell 13, 433–445 (2013). · DOI · Paper page
- Gallage, S. et al. A researcher’s guide to preclinical mouse NASH models. Nat. Metab. 4, 1632–1649 (2022). · DOI · Paper page
- Angulo, P. et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 149, 389–397 (2015). · DOI · Paper page
- Reid, D. T. et al. Kupffer cells undergo fundamental changes during the development of experimental NASH and are critical in initiating liver damage and inflammation. PLoS One 11, e0159524 (2016). · DOI · Paper page
- Kahn, R. A., Goddard, C. & Newkirk, M. Chemical and immunological characterization of the 21-kDa ADP-ribosylation factor of adenylate cyclase. J. Biol. Chem. 263, 8282–8287 (1988). · DOI · Paper page
- Franco, M., Chardin, P., Chabre, M. & Paris, S. Myristoylation-facilitated binding of the G protein ARF1GDP to membrane phospholipids is required for its activation by a soluble nucleotide exchange factor. J. Biol. Chem. 271, 1573–1578 (1996). · DOI
- Priyamvada, L. et al. Inhibition of vaccinia virus L1 N-myristoylation by the host N-myristoyltransferase inhibitor IMP-1088 generates non-infectious virions defective in cell entry. PLoS Pathog. 18, e1010662 (2022). · DOI
- Mousnier, A. et al. Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus. Nat. Chem. 10, 599–606 (2018). · DOI · Paper page
- Gaston-Massuet, C. et al. Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans. Proc. Natl Acad. Sci. USA 108, 11482–11487 (2011). · DOI · Paper page
- Wang, X., Spandidos, A., Wang, H. & Seed, B. PrimerBank: a PCR primer database for quantitative gene expression analysis, 2012 update. Nucleic Acids Res. 40, D1144–D1149 (2012). · DOI · Paper page
- Pelz, O., Gilsdorf, M. & Boutros, M. web cellHTS2: a web application for the analysis of high-throughput screening data. BMC Bioinformatics 11, 185 (2010). · DOI · Paper page
Cited by
Senescence as a therapeutic target in cancer and age-related diseases
McHugh, D., Durán, I., & Gil, J. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01074-4 · Cited by 197
Self-citationEmerging insights in senescence: pathways from preclinical models to therapeutic innovations
Mansfield, L., Ramponi, V., Gupta, K., Stevenson, T., Mathew, A. B., Barinda, A. J., Herbstein, F., & Morsli, S. (2024) · npj Aging · doi:10.1038/s41514-024-00181-1 · Cited by 88
Metabolic remodeling in cancer and senescence and its therapeutic implications
Kim, Y., Jang, Y., Kim, M.-S., & Kang, C. (2024) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2024.02.008 · Cited by 36
Wakita, M., Ito, K., Fujii, K., Sakamoto, D., Mikawa, T., Sugawara, S., Zhou, X., Park, J. H., Miyagawa, H., Motooka, D., et al. (2026) · Nature Aging · doi:10.1038/s43587-025-01057-z · Cited by 9
Metadata
- Authors
- McHugh, D., Sun, B., Gutierrez-Muñoz, C., Hernández-González, F., Mellone, M., Guiho, R., Duran, I., Pombo, J., Pietrocola, F., Birch, J., Kallemeijn, W. W., Khadayate, S., Dharmalingam, G., Vernia, S., Tate, E. W., Martínez-Barbera, J. P., Withers, D. J., Thomas, G. J., Serrano, M., & Gil, J.
- Venue
- Nature Cell Biology
- Published
- 2023-11-27
- Volume
- 25
- Issue
- 12
- Pages
- 1804-1820
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W4389058414
- Cited by
- 59
- References
- 31
- FWCI
- 8.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: COPI vesicle formation and N-myristoylation are targetable vulnerabilities of senescent cells. https://app.cochat.ai/papers/10.1038/s41556-023-01287-6
- The paper
- McHugh, D., Sun, B., Gutierrez-Muñoz, C., Hernández-González, F., Mellone, M., Guiho, R., Duran, I., Pombo, J., Pietrocola, F., Birch, J., Kallemeijn, W. W., Khadayate, S., Dharmalingam, G., Vernia, S., Tate, E. W., Martínez-Barbera, J. P., Withers, D. J., Thomas, G. J., Serrano, M., & Gil, J. (2023). COPI vesicle formation and N-myristoylation are targetable vulnerabilities of senescent cells. Nature Cell Biology. https://doi.org/10.1038/s41556-023-01287-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.